C. Caroti

747 total citations
21 papers, 419 citations indexed

About

C. Caroti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, C. Caroti has authored 21 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in C. Caroti's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Gastric Cancer Management and Outcomes (5 papers). C. Caroti is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (7 papers) and Gastric Cancer Management and Outcomes (5 papers). C. Caroti collaborates with scholars based in Italy, Netherlands and Ukraine. C. Caroti's co-authors include Editta Baldini, P. Pronzato, Paolo Bruzzi, Enrico Aitini, A. Contu, Fulvio Brema, Giovanna Cavazzini, Lucia Del Mastro, Giuseppe Canavese and Marco Venturini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

C. Caroti

21 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Caroti Italy	9	330	158	138	72	69	21	419
Elisa García-Garré Spain	8	392 1.2×	175 1.1×	122 0.9×	62 0.9×	66 1.0×	16	547
Hak Min Lee South Korea	12	212 0.6×	146 0.9×	84 0.6×	81 1.1×	23 0.3×	32	389
Maria Farooq United States	7	168 0.5×	294 1.9×	201 1.5×	115 1.6×	45 0.7×	15	437
Brian M.J. Cantwell United Kingdom	12	236 0.7×	51 0.3×	126 0.9×	83 1.2×	32 0.5×	21	369
Monica Zuradelli Italy	11	186 0.6×	70 0.4×	55 0.4×	87 1.2×	133 1.9×	34	378
Jeffrey C. Goh Australia	11	167 0.5×	39 0.2×	109 0.8×	91 1.3×	26 0.4×	35	376
P Autzen United Kingdom	7	213 0.6×	89 0.6×	250 1.8×	115 1.6×	26 0.4×	10	399
Uwe-Jochen Göhring Germany	13	199 0.6×	74 0.5×	163 1.2×	105 1.5×	35 0.5×	35	531
Matthew P. Borst United States	8	116 0.4×	65 0.4×	149 1.1×	46 0.6×	54 0.8×	11	399
Joanna Huszno Poland	11	193 0.6×	102 0.6×	131 0.9×	146 2.0×	79 1.1×	37	425

Countries citing papers authored by C. Caroti

Since Specialization

Citations

This map shows the geographic impact of C. Caroti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Caroti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Caroti more than expected).

Fields of papers citing papers by C. Caroti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Caroti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Caroti. The network helps show where C. Caroti may publish in the future.

Co-authorship network of co-authors of C. Caroti

This figure shows the co-authorship network connecting the top 25 collaborators of C. Caroti. A scholar is included among the top collaborators of C. Caroti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Caroti. C. Caroti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Paudice, Michele, Marco Greppi, Serafina Mammoliti, et al.. (2023). The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers. Frontiers in Immunology. 14. 1221605–1221605. 6 indexed citations

2.

Messina, Carlo, Chiara Dellepiane, C. Caroti, et al.. (2015). A Case of Advanced Mucinous Adenocarcinoma of Bladder in an Adult Patient Treated With Capecitabine-Based Chemotherapy and Review of Literature. Clinical Genitourinary Cancer. 13(5). e365–e368. 4 indexed citations

3.

Boni, C., Marcello Tiseo, Luca Boni, et al.. (2012). Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). British Journal of Cancer. 106(4). 658–665. 19 indexed citations

4.

Santini, Daniele, Gaia Schiavon, Bruno Vincenzi, et al.. (2011). Receptor Activator of NF-kB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients. PLoS ONE. 6(4). e19234–e19234. 136 indexed citations

5.

Giorgio, Elisa, C. Caroti, Francesca Mattioli, et al.. (2011). Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation. Cancer Chemotherapy and Pharmacology. 68(5). 1355–1361. 12 indexed citations

6.

Santini, Daniele, Bruno Vincenzi, Antonio Russo, et al.. (2010). Association of receptor activator of NF-kb (RANK) expression with bone metastasis in breast carcinomas.. Journal of Clinical Oncology. 28(15_suppl). 1053–1053. 2 indexed citations

7.

Boni, Luca, Giovanni Selvaggi, Filippo de Marinis, et al.. (2008). Induction chemotherapy followed by thoracic irradiation with or without concurrent chemotherapy in locally advanced inoperable NSCLC: A randomized phase III trial. Journal of Clinical Oncology. 26(15_suppl). 7520–7520. 2 indexed citations

8.

Venturini, Marco, Lucia Del Mastro, Enrico Aitini, et al.. (2005). Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(23). 1724–1733. 107 indexed citations

9.

Aschele, C., Gian Andrea Binda, Franco Decian, et al.. (2004). A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC). Journal of Clinical Oncology. 22(14_suppl). 3637–3637. 6 indexed citations

10.

Pasetto, Lara Maria, Sara Lonardi, C. Caroti, et al.. (2004). Phase I study of weekly oxaliplatin (OXA) + 5-fluorouracil continuous infusion (FU CI) in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology. 22(14_suppl). 3770–3770. 4 indexed citations

11.

Pasetto, Lara Maria, Sara Lonardi, C. Caroti, et al.. (2004). Phase I study of weekly oxaliplatin (OXA) + 5-fluorouracil continuous infusion (FU CI) in patients (pts) with advanced colorectal cancer (CRC). Journal of Clinical Oncology. 22(14_suppl). 3770–3770. 1 indexed citations

12.

Lonardi, Sara, Myriam Paris, C. Caroti, et al.. (2004). Gemcitabine (GEM) as salvage therapy in patients (pts) with advanced colorectal cancer (CRC) refractory to 5-fluorouracil (FU), irinotecan (IRI) and oxaliplatin (OXA). Journal of Clinical Oncology. 22(14_suppl). 3577–3577. 3 indexed citations

13.

Lonardi, Sara, Myriam Paris, C. Caroti, et al.. (2004). Gemcitabine (GEM) as salvage therapy in patients (pts) with advanced colorectal cancer (CRC) refractory to 5-fluorouracil (FU), irinotecan (IRI) and oxaliplatin (OXA). Journal of Clinical Oncology. 22(14_suppl). 3577–3577. 2 indexed citations

14.

Sobrero, Alberto, Alfredo Guglielmi, Massimo Círillo, et al.. (2001). 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer. British Journal of Cancer. 84(8). 1023–1028. 12 indexed citations

15.

Boccardo, Francesco, A. Rubagotti, D. Amoroso, et al.. (2001). Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer Patients: Results of an Italian Cooperative Study. Journal of Clinical Oncology. 19(22). 4209–4215. 56 indexed citations

16.

Sobrero, Alberto, Alberto Zaniboni, Giovanni Luca Frassineti, et al.. (2000). Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study. Annals of Oncology. 11(11). 1413–1420. 15 indexed citations

17.

Aschele, C., Alfredo Guglielmi, Giovanni Luca Frassineti, et al.. (1998). Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study. British Journal of Cancer. 77(2). 341–346. 11 indexed citations

18.

Mammoliti, Serafina, Laura Merlini, C. Caroti, & Luigi Gallo. (1996). Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients. Breast Cancer Research and Treatment. 37(1). 93–96. 11 indexed citations

19.

Canavese, Giuseppe, A. Catturich, C. Caroti, et al.. (1989). The Role of Surgery in the Combined Treatment of Locally Advanced Breast Cancer. Oncology. 46(6). 353–356. 5 indexed citations

20.

Badellino, F, Giuseppe Canavese, A. Catturich, et al.. (1988). Chemotherapy and surgery related to breast cancer biology. 1(1). 74–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact